Ask an Expert

Question of the Day

Eric J. Nestler, M.D., Ph.D. - Brain & behavior research expert on depression
September 11, 2013

Several rapidly acting antidepressants are currently in clinical trial, such as ketamine (see 2011 Highlights, Dr. Zarate, on p.2). These rapidly acting agents have novel mechanisms compared to currently available antidepressants and could offer significant improvement to patients who do not fully respond to today's medications. In addition, efforts continue to identify even more antidepressant medications with novel mechanisms of action.


Eric J. Nestler, M.D., Ph.D.
Scientific Council Member
Nash Family Professor of Neuroscience
Chair, Department of Neuroscience
Director, Friedman Brain Institute
Mount Sinai School of Medicine

Jay N. Giedd, M.D. - brain & behavior research expert on schizophrenia
Q How common is relapse after stabilization in schizophrenia?
A Jay N. Giedd, M.D. of the National Institute of Mental Health received the... More >
Marc G. Caron, Ph.D. - brain & behavior research expert on schizophrenia
Q How likely is it for schizophrenia to be passed along to later generations?
A Marc G. Caron, Ph.D., of the Duke University Medical Center received the... More >